Adverse Events Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module

Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2025-12-26 @ 2:23 AM
NCT ID: NCT00024102
Description: None
Frequency Threshold: 0
Time Frame: Reported at the end of each cycle while patients were receiving protocol therapy.
Study: NCT00024102
Study Brief: Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Standard Chemotherapy (CMF) CMF: cyclophosphamide (100 mg/m\^2 orally days 1-14)+ MTX (40 mg/m\^2 by IV days 1 and 8) + 5-FU (600 mg/m\^2 by IV days 1 and 8) repeated every 28 days for 6 cycles None None 15 131 121 131 View
Standard Chemotherapy (AC) AC: Cyclophosphamide (600 mg/m\^2 by IV on day 1)+ doxorubicin (60 mg/m\^2 by IV on day 1) repeated every 21 days for 4 cycles None None 17 181 168 181 View
Capecitabine Capecitabine (2000 mg/m\^2 in 2 doses days 1-14) repeated every 21 days for 6 cycles None None 26 299 279 299 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Febrile neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 5 View
Disseminated intravascular coagulation SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 5 View
Hemoglobin decreased SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 5 View
Lymphatics SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 5 View
Transfusion: pRBCs SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 5 View
Arrhythmia supraventricular SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 5 View
Cardiac disorder SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 5 View
Edema SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 5 View
Left ventricular failure SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 5 View
Myocardial ischemia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 5 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Colitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Esophagitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Gastritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Mucositis oral SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Typhlitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Chest pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 5 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 5 View
Anorectal infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Infection with grade 3 or 4 neutropenia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Infection without neutropenia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Infectious colitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Upper respiratory infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Aspartate aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Coagulopathy SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Creatinine increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
INR increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Leukocyte count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Lymphocyte count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Neutrophil count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Platelet count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Anorexia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Blood glucose increased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Blood uric acid increased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum albumin decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum calcium decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum glucose decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum magnesium decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum potassium decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum sodium decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Bone pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 5 View
Ataxia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Ischemia cerebrovascular SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Peripheral motor neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Speech disorder SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Syncope SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Rash/Dermatitis BMT SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Vaginal hemorrhage SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 5 View
Adult respiratory distress syndrome SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Bronchospasm SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Dyspnea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Dyspnea (shortness of breath) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Hypoxia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Pleural effusion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Pneumonitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Hand-and-foot syndrome SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Rash desquamating SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Peripheral arterial ischemia SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Phlebitis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Thrombosis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hemoglobin decreased SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 5 View
Hemolysis SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 5 View
Lymphatics SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 5 View
Transfusion: pRBCs SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 5 View
Atrial fibrillation SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 5 View
Cardiac disorder SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 5 View
Edema SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 5 View
Myocardial ischemia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 5 View
Sinus tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 5 View
Cataract SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 5 View
Conjunctivitis SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 5 View
Diplopia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 5 View
Flashing vision SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 5 View
Retinal detachment SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 5 View
Vision blurred SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 5 View
Watering eyes SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 5 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Colitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Dry mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Gastritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Gastrointestinal disorder SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Hemorrhoids SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Mucositis oral SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Rectal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Typhlitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 5 View
Chest pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 5 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 5 View
Fever SYSTEMATIC_ASSESSMENT General disorders MedDRA 5 View
Gait abnormal SYSTEMATIC_ASSESSMENT General disorders MedDRA 5 View
General symptom SYSTEMATIC_ASSESSMENT General disorders MedDRA 5 View
Injection site reaction SYSTEMATIC_ASSESSMENT General disorders MedDRA 5 View
Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 5 View
Hepatobiliary disease SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA 5 View
Biliary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Catheter related infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Infection with grade 3 or 4 neutropenia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Infection with unknown ANC SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Infection without neutropenia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Sepsis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Skin infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 5 View
Bruising SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 5 View
Vascular access complication SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 5 View
Activated partial thromboplastin time prolonged SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Alanine aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Alkaline phosphatase SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Alkaline phosphatase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Aspartate aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Blood bilirubin increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Creatinine increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Gamma-glutamyltransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
INR increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Laboratory test abnormal SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Leukocyte count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Lymphocyte count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Neutrophil count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Neutrophils/granulocytes (ANC/AGC) for BMT studies, if specified in the protocol. SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Platelet count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Platelets for BMT studies, if specified in the protocol. SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Weight loss SYSTEMATIC_ASSESSMENT Investigations MedDRA 5 View
Anorexia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Blood glucose increased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Blood uric acid increased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum albumin decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum calcium decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum glucose decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum phosphate decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum potassium decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum potassium increased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum sodium decreased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Serum sodium increased SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 5 View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 5 View
Arthritis SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 5 View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 5 View
Bone pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 5 View
Musculoskeletal disorder SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 5 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 5 View
Myelodysplasia SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 5 View
Ataxia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Depressed level of consciousness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Dysgeusia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Intracranial hemorrhage SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Ischemia cerebrovascular SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Neurological disorder NOS SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Peripheral motor neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Peripheral sensory neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Sense of smell SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Speech disorder SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Syncope SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 5 View
Agitation SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 5 View
Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 5 View
Confusion SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 5 View
Depression SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 5 View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 5 View
Urogenital disorder SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 5 View
Pelvic pain SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 5 View
Vaginal inflammation SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 5 View
Allergic rhinitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Bronchial obstruction SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Dyspnea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Dyspnea (shortness of breath) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Hypoxia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Pleural effusion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Pneumothorax SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Respiratory disorder SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 5 View
Alopecia SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Hand-and-foot syndrome SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Nail disorder SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Pain of skin SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Pigmentation changes (e.g., vitiligo) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Pruritus SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Rash desquamating SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Skin disorder SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Skin hyperpigmentation SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Sweating SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 5 View
Flushing SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Hemorrhage SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Hot flashes SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Thrombosis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 5 View
Febrile neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 5 View